http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8647385

Outgoing Links

Predicate Object
contentType Case Reports|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 946
issn 1556-0864
issueIdentifier 5
pageRange 942-946
publicationName Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
startingPage 942
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_45df3ef785bb27d21da0f886965a8a1c
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_73bd6f711f9a14200e34ee253ed251d7
bibliographicCitation Ou SH, Kwak EL, Siwak-Tapp C, Dy J, Bergethon K, Clark JW, Camidge DR, Solomon BJ, Maki RG, Bang YJ, Kim DW, Christensen J, Tan W, Wilner KD, Salgia R, Iafrate AJ. Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification. J Thorac Oncol. 2011 May;6(5):942–6. doi: 10.1097/jto.0b013e31821528d3. PMID: 21623265.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91246700063e17a85fdbc6fcca5ba910
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29f5f8cf495c982d81e015ac5ffa43ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45efdb864e1eb4e86e43b9f9c10cfe7e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dce68b61044e581129b4e52f14a01e6b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d1bd6262306b3a1115e56aacb46db97
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43ae8ac6d35f3724954eca3647aaf899
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c872cc3e22b50f5592483cb391356028
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1915f73e05fa3df698dab4c3ad332961
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c790a46fb87d249a6a122c846a14cbe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5afe11089fe1a36156fe1817e6cc6b98
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2efafb596ce4921a0bacaec62d2043b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef6dbe0e0601c591a99adb6fb3d4936b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59df44238ad73f1b247e4626ec9fd93a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1ae77f61a1dbb2c8ca12c4d3280ecf4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd6d164b52eb10c7fb5e62fca4a24ccb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f498b4b4d5df32b174de599886447edb
date 201105
identifier https://doi.org/10.1097/jto.0b013e31821528d3
https://pubmed.ncbi.nlm.nih.gov/21623265
isPartOf https://portal.issn.org/resource/ISSN/1556-0864
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33311
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification
discusses http://id.nlm.nih.gov/mesh/M0493054
http://id.nlm.nih.gov/mesh/M0553416
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0443627
http://id.nlm.nih.gov/mesh/M0468309
http://id.nlm.nih.gov/mesh/M0027150
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0029482
http://id.nlm.nih.gov/mesh/M0228330
http://id.nlm.nih.gov/mesh/M0005997
http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M000754277
http://id.nlm.nih.gov/mesh/M0018226
http://id.nlm.nih.gov/mesh/M0024707
http://id.nlm.nih.gov/mesh/M0328256
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D020794Q000037
http://id.nlm.nih.gov/mesh/D011720Q000627
http://id.nlm.nih.gov/mesh/D002289Q000188
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D017978Q000235
http://id.nlm.nih.gov/mesh/D019859Q000235
http://id.nlm.nih.gov/mesh/D011725Q000627
http://id.nlm.nih.gov/mesh/D058750Q000187
http://id.nlm.nih.gov/mesh/D005784
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000077548
http://id.nlm.nih.gov/mesh/D000911Q000008
http://id.nlm.nih.gov/mesh/D047428Q000627
http://id.nlm.nih.gov/mesh/D016190Q000008
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000093542
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D061067
http://id.nlm.nih.gov/mesh/D003841Q000031
http://id.nlm.nih.gov/mesh/D002289Q000235
http://id.nlm.nih.gov/mesh/D002289Q000473
http://id.nlm.nih.gov/mesh/D000068258
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D003841Q000008
http://id.nlm.nih.gov/mesh/D000077547
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID160644611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243164928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621

Total number of triples: 85.